Center-Authored Papers

Filters: Author is Landgren, Ola  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Birmann BM, Neuhouser ML, Rosner B, Albanes D, Buring JE, Giles GG, Lan Q, Lee I-M, Purdue MP, Rothman N et al..  2012.  Pre-diagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.. Blood. 120(25):4929-37. Abstract
D
Dimopoulos M, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, García-Sanz R, Munshi N, Anderson KC et al..  2014.  Treatment recommendations for patients with Waldenström's Macroglobulinemia (WM) and related disorders: consensus from the Seventh International Workshop on WM.. Blood. Abstract
H
Hofmann JN, Birmann BM, Teras LR, Pfeiffer RM, Wang Y, Albanes D, Baris D, Colditz GA, De Roos AJ, Giles GG et al..  2016.  Low levels of circulating adiponectin are associated with multiple myeloma risk in overweight and obese individuals.. Cancer research. Abstract
L
Landgren O, Gilbert ES, Rizzo DJ, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB et al..  2009.  Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.. Blood. 113(20):4992-5001. Abstract
R
Rizzo DJ, Curtis RE, Socié G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers MED, Friedman DL et al..  2009.  Solid cancers after allogeneic hematopoietic cell transplantation.. Blood. 113(5):1175-83. Abstract